These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 19144901

  • 1. Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.
    Nass R, Merchant KM, Ryan T.
    Mol Interv; 2008 Dec; 8(6):284-93. PubMed ID: 19144901
    [Abstract] [Full Text] [Related]

  • 2. Caenorhabditis elegans: a versatile platform for drug discovery.
    Artal-Sanz M, de Jong L, Tavernarakis N.
    Biotechnol J; 2006 Dec; 1(12):1405-18. PubMed ID: 17109493
    [Abstract] [Full Text] [Related]

  • 3. [Study of molecular mechanism of anti-Parkinson's disease traditional Chinese medicine using model of Caenorhabditis elegans].
    Wang X, Wang X, Gao H, Wang D.
    Zhongguo Zhong Yao Za Zhi; 2010 Mar; 35(5):661-3. PubMed ID: 20506834
    [Abstract] [Full Text] [Related]

  • 4. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease.
    Harrington AJ, Hamamichi S, Caldwell GA, Caldwell KA.
    Dev Dyn; 2010 May; 239(5):1282-95. PubMed ID: 20108318
    [Abstract] [Full Text] [Related]

  • 5. Modeling dopamine neuron degeneration in Caenorhabditis elegans.
    Tucci ML, Harrington AJ, Caldwell GA, Caldwell KA.
    Methods Mol Biol; 2011 May; 793():129-48. PubMed ID: 21913098
    [Abstract] [Full Text] [Related]

  • 6. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
    Locke CJ, Fox SA, Caldwell GA, Caldwell KA.
    Neurosci Lett; 2008 Jul 11; 439(2):129-33. PubMed ID: 18514411
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
    Youssef K, Tandon A, Rezai P.
    Integr Biol (Camb); 2019 May 01; 11(5):186-207. PubMed ID: 31251339
    [Abstract] [Full Text] [Related]

  • 9. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.
    Mandel SA, Fishman T, Youdim MB.
    Parkinsonism Relat Disord; 2007 May 01; 13 Suppl 3():S242-7. PubMed ID: 18267243
    [Abstract] [Full Text] [Related]

  • 10. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
    Outeiro TF, Giorgini F.
    Biotechnol J; 2006 Mar 01; 1(3):258-69. PubMed ID: 16897706
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.
    Jadiya P, Chatterjee M, Sammi SR, Kaur S, Palit G, Nazir A.
    Biochem Biophys Res Commun; 2011 Sep 23; 413(2):306-10. PubMed ID: 21889494
    [Abstract] [Full Text] [Related]

  • 13. C. elegans as a genetic model system to identify Parkinson's disease-associated therapeutic targets.
    Vistbakka J, VanDuyn N, Wong G, Nass R.
    CNS Neurol Disord Drug Targets; 2012 Dec 23; 11(8):957-64. PubMed ID: 23244419
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Parkinson's disease: insights from non-traditional model organisms.
    Pienaar IS, Götz J, Feany MB.
    Prog Neurobiol; 2010 Dec 23; 92(4):558-71. PubMed ID: 20851733
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application.
    Yasuhara T, Date I.
    Cell Transplant; 2007 Dec 23; 16(2):125-32. PubMed ID: 17474294
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.